IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WHO Have GENETIC HEART DISEASE

Little is known of ICD therapy in patients who receive implantable cardioverter-defibrillators (ICD) for genetic heart disease (GHD). The aim of this study was to determine if ICD therapy (Rx) differed amongst GHD patients, and between GHD patients and patients who did not have GHD, including